Overview of the CD38 antibody in multiple myeloma
Overview of the CD38 antibody in multiple myeloma Dr Plesner talks to ecancertv at ICMM 2016 about the use of CD38 monoclonal antibodies for patients with multiple myeloma.
Read MoreOverview of the CD38 antibody in multiple myeloma Dr Plesner talks to ecancertv at ICMM 2016 about the use of CD38 monoclonal antibodies for patients with multiple myeloma.
Read MorePfizer moves US court against Aurobindo Pharma, Dr Reddy’s on cancer drug Hyderabad, November 17 Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion […]
Read MorePfizer moves US court against Aurobindo Pharma, Dr. Reddy’s on cancer drug Pfizer filed the possible patent infringement petition against both the companies in the United States District Court for the District of Delaware on two counts last week Pfizer Inc. and its group companies fileda petition in a U.S. court against Aurobindo Pharma Ltd […]
Read MoreEndometrial Cancer Therapeutics Market: Adenocarcinoma Segment to Lead the Market Endometrial Cancer Therapeutics: Introduction Endometrial cancer starts in the inner lining of the uterus, and the cells grow out of control. It usually affect women past menopause, and the risk increases above the age of 40. Obesity, diabetes, high pressure, history of infertility, irregular periods […]
Read MoreIntroduction to “Immunotherapies for Multiple Myeloma” Note: In lieu of an abstract, this is an excerpt from the first page. Multiple myeloma (MM) is the second most common hematological cancer after diffuse large B-cell lymphoma, accounting for about 10% of all blood cancers […] View Full-Text This is an open access article distributed under the […]
Read More